BRAZILIAN PHARMACEUTICAL CLINICAL SERVICES- A DOCUMENTARY ANALYSIS
Author(s)
Chagas MO1, Porto CC2, Chaveiro N2, Noll M3, Assis DL4, Chagas FA5, Chagas VO6
1Universidade Federal de Goiás, Jataí, Brazil, 2Universidade Federal de Goiás, Goiânia, Goiás, Brazil, 3Instituto Federal Goiano, Ceres, Brazil, 4Universidade Federal de Goiás, Jataí, Goiás, Brazil, 5Instituto Federal de Goiás, Jataí, Goiás, Brazil, 6Universidade Federal de Goiás, Goiânia, Brazil
The publication of Law 13.021/2014, which recognized pharmacy as a healthcare facility, and of Resolution 585/2013, which regulated the clinical attributions of the pharmacists, was a great advancement for the clinical pharmacy field in the provision of clinical services according to the philosophy of pharmaceutical care. Considering that the legislation has not been updated since the publication of these documents as regards the terms used and the description of pharmaceutical services, the objective of this study was to describe the different clinical services defined in the guidelines of the Brazilian Ministry of Health and the Federal Council of Pharmacy of Brazil. Two documents were analyzed, namely: “Pharmaceutical services in primary health care” published by the Ministry of Health in 2014 and “Pharmaceutical services directly aimed at the patient, family and community: contextualization and conceptual framework” published by the Federal Council of Pharmacy in 2016. In the documents, nine clinical services have been described: screening, health education, management of minor illness, dispensing, therapeutic drug monitoring, medication reconciliation, medication therapy review, disease management, and pharmacotherapeutic follow-up. The provision of these services depends on the patients’ clinical conditions, which can require more than one type of service, the structure of the pharmacy with availability of privative environments, professional qualification with effective communication capable of establishing a patient-pharmacist relationship and communication with the health team, in addition to clinical reasoning in the decision making and in the interventions carried out. In conclusion, these different pharmaceutical clinical services can be offered in community pharmacies, hospitals, outpatient clinics, households, among others, to meet the needs and health conditions of patients, families, and communities.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PCP29
Topic
Health Policy & Regulatory
Disease
Multiple Diseases